Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120%fool.comThis clinical-stage biotech develops antibody therapies for cancer and infectious diseases, leveraging proprietary discovery platforms.
Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfoliofool.comIt's about striking that perfect balance between chasing growth and protecting what you already have.
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Yearfool.comThis clinical-stage biotech develops targeted cancer therapies, leveraging bispecific antibodies and strategic industry partnerships.
Vertiv Stock: Buy, Sell, or Hold?fool.comVertiv has seen incredibly strong demand from data center operators for its cooling and power solutions.
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025fool.comKrystal Biotech develops redosable gene therapies targeting rare skin diseases, with a late-stage clinical pipeline and expanding portfolio.
Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26%fool.comScholar Rock develops therapies for neuromuscular and oncological diseases, leveraging a proprietary platform to target unmet medical needs.
Why Cleveland's Culture Scene Makes It a Retirement Pick That Doesn't Feel "Sleepy"fool.comCleveland may sound like a sleepy little midwestern town. However, it's anything but sleepy.
Alphabet Has a Plan for Worldwide AI Dominancefool.comWill the tech giant be able to follow through on its aspirations?
This Fund Sold its Entire Stake in SSR Mining Stock After a 200% Rally. Should You Too?fool.comSSR Mining is a global precious metals producer with operations spanning gold, silver, and base metals across four continents.
This 5% Dividend Stock Looks Safer Than You Thinkfool.comWith high-occupancy and long-term lease terms, this REIT is built for stability. But, is it still a buy?
Banking Crisis 2.0? The "Contagion" ETF That Gains 3% for Every 1% Banks Dropfool.comThe Direxion Daily Financial Bear 3X Shares is still useful for some traders, but don't expect it to act like 2008 is back.
Uber's CEO Just Delivered Disappointing News for Tesla Stock Investorsfool.comIt's time for investors to think about the progression of autonomous vehicle technology.
1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $160 and Hold for the Long Termfool.comPalo Alto's business is going from strength to strength as it prepares customers for an increasingly dangerous cyber landscape.
RWC Asset Advisors Sells Out of Entire Nio Position for $79.8 Millionfool.comShanghai-based Nio designs and sells smart electric vehicles, leveraging proprietary battery swapping and integrated service solutions.
